Clinical Trial Update: Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating anlotinib hydrochloride capsule in small cell lung cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN